Chronic Tension-Type Headache (≥15 Days/Month)
Investigational adjunct for chronic tension-type headache (≥15 days/month) with persistent pericranial muscle tenderness; small case series.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for chronic tension-type headache. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Tier C (investigational). There are no published controlled trials. Evidence-based care for chronic tension-type headache: amitriptyline (the strongest RCT support for prevention), mirtazapine and venlafaxine as alternatives, cognitive-behavioral therapy and biofeedback (strong evidence), exercise therapy, stress management, sleep optimization, treatment of mood and anxiety comorbidity, and avoidance of medication-overuse headache from frequent analgesic use. Acute attacks: NSAIDs, acetaminophen - used sparingly to avoid medication-overuse headache.
- Main risks
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the upper trapezius or temporal region for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of headache for 1 to 3 days
- Delay of amitriptyline trial, CBT, biofeedback, and exercise - all with RCT support
- Placebo response masking medication-overuse headache or secondary causes
- Risk of perpetuating headache attribution to a peripheral cause when central sensitization is the driver
- Who should not consider this
- Patients with red-flag headache features (sudden onset, neurological deficits, fever, immunosuppression, cancer history, age over 50 new-onset)
- Patients with medication-overuse headache who need analgesic detoxification first
- Patients who have not tried amitriptyline (or alternative) at adequate dose and duration
- Patients with untreated depression or anxiety driving the headache
- Patients on anticoagulants, with hemophilia, or with severe anemia
- Patients with active dermatitis or broken skin at planned placement sites
- What to ask your clinician
- Have we excluded migraine, cluster headache, cervicogenic headache, and medication-overuse headache?
- Have I tried amitriptyline (or mirtazapine, venlafaxine) at adequate doses and duration?
- Have I tried CBT, biofeedback, and structured stress-management?
- Am I using analgesics more than 10 to 15 days per month (medication-overuse headache risk)?
- Are mood, anxiety, sleep, and stress being addressed?
- Where exactly will leeches be placed, and what is the practitioner's plan if headache worsens?
- What is the Aeromonas-prevention protocol?
- When to seek urgent care
- Thunderclap (worst-of-life) headache (possible subarachnoid hemorrhage - 911)
- Headache with fever, stiff neck, photophobia, or altered mental status (possible meningitis)
- Sudden vision change, speech difficulty, focal weakness, or seizure
- Jaw claudication, scalp tenderness, or vision change in age over 50 (possible giant cell arteritis)
- New-onset headache during pregnancy or postpartum
- Bleeding from a bite site lasting more than 24 hours
- Hives, facial or throat swelling, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for tension-type headache.
- No controlled trials support efficacy; chronic tension-type headache responds best to amitriptyline plus CBT plus exercise.
- It does not address medication-overuse headache, which requires analgesic detoxification.
- Central sensitization is the driver - peripheral interventions alone are insufficient.
- It does not replace evidence-based prevention with RCT support.
Safety cross-references
Clinical Profile
- Category
- neurological
- ICD-10
- G44.221, G44.229
- Safety tier
- low
Evidence Summary
Chronic tension-type headache (CTTH) is defined per ICHD-3 as headache ≥15 days/month for ≥3 months with a bilateral pressing/tightening quality. Preventive options include amitriptyline (first-line), mirtazapine, and venlafaxine. Medication-overuse headache (NSAID, analgesic, triptan) must be excluded and addressed first. This entry is distinct from the episodic tension-headache registry entry, which addresses lower-frequency presentations. No controlled clinical trial or published case series of leech therapy for chronic tension-type headache has been reported; any use is investigational and mechanistic only.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Patel D et al. (2021), n=20
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Medication-overuse headache without prior taper
- Secondary headache from undiagnosed cause
- Cervical instability or vertebrobasilar insufficiency
Related Conditions
Cervical Radiculopathy
Off-label use with one RCT (Michalsen 2018) showing significant pain reduction at 7 days in cervical radiculopathy without surgical indication.
Lumbar Radiculopathy (Sciatica)
Off-label use with controlled trial evidence (n=80) showing leg pain and Oswestry score improvement at 4-12 weeks in non-surgical lumbar disc disease.
Migraine
Investigational use with case-series evidence for reduction of migraine frequency and intensity; mechanism plausible via reduction of cervico-cranial venous congestion.
Tension-Type Headache
Investigational use with small case series suggesting frequency reduction in chronic tension headache via reduction of pericranial muscle tension and venous congestion.